Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,409–1,416 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Cyclo Therapeutics Inc. Trappsol Cyclo - (TransportNPC) Niemann-Pick Disease Type C Phase 3 Ongoing Intravenous Genetic Disorder
Cytodyn Inc Leronlimab (PRO 140) HIV BLA Filing Subcutaneous Anti-HIV
Cytodyn Inc Leronlimab Non-alcoholic steatohepatitis (NASH) Phase 2 Subcutaneous Gastroenterology
Cytodyn Inc Leronlimab Chronic inflammation Phase 2 Trial Planned Subcutaneous Immunology
Cytodyn Inc Leronlimab with trifluridine plus tipiracil (TAS-102) and bevacizumab CCR5+, microsatellite stable (MSS), relapsed or refractory metastatic colorectal cancer (mCRC) Phase 2 Trial Planned Intravenous Oncology
Cytodyn Inc Leronlimab Relapsed/refractory micro-satellite stable colorectal cancer (CRC) Phase 2 Data Released Subcutaneous Oncology
Cytodyn Inc Leronlimab (CD16) Covid-19 (critically ill) Phase 3 Trial Discontinued Subcutaneous COVID-19
Cytodyn Inc Leronlimab COVID-19 (critically ill) Phase 3 Subcutaneous COVID-19